Fisher & Paykel Healthcare Corporation Limited (ASX:FPH)
Australia · Delayed Price · Currency is AUD 33.02
-0.01 (-0.04%)
At close: Dec 3, 2025
ASX:FPH Market Cap
ASX:FPH has a market cap or net worth of 19.69 billion as of December 3, 2025. Its market cap has decreased by -1.30% in one year.
Market Cap
19.69B
Enterprise Value
19.56B
Revenue
1.89B
Ranking
n/a
PE Ratio
51.40
Stock Price
33.02
Market Cap Chart
Since February 28, 1992, ASX:FPH's market cap has increased from 173.53M to 19.69B, an increase of 11,247.59%. That is a compound annual growth rate of 15.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 3, 2025 | 19.69B | -3.33% |
| Dec 31, 2024 | 20.37B | 59.11% |
| Dec 29, 2023 | 12.80B | 4.87% |
| Dec 30, 2022 | 12.21B | -31.40% |
| Dec 31, 2021 | 17.79B | 0.44% |
| Dec 31, 2020 | 17.72B | 44.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 88.65B |
| Pro Medicus | 27.39B |
| Cochlear | 18.00B |
| Sonic Healthcare | 11.65B |
| Ramsay Health Care | 8.57B |
| Ansell | 5.21B |
| Telix Pharmaceuticals | 5.10B |
| Mesoblast | 3.43B |